, Volume 24, Supplement 1, pp 28–30 | Cite as

Complete Resolution of Enterocolic Fistulas with Infliximab

  • Joana NunesEmail author
  • Paula M. Santos
  • Lourdes Tavares
Case Report


Fistulas are a frequent and serious complication of Crohn's disease. Most of the literature has been focused on perianal fistulas, which are by far the most frequent. The effectiveness of treatment with infliximab in fistulizing Crohn's disease was demonstrated in the ACCENT II trial. In that study, however, all patients had external fistulas, and the majority of those were perianal fistulas. The response to fistula treatment in other locations was not evaluated.


Infliximab Chronic Anal Fissure Perianal Fistula Aphthous Ulcer Internal Fistula 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The authors would like to thank GEDII (Portuguese Group for the Study of Inflammatory Bowel Disease) for reviewing the case report. Dr Nunes received honoraria for the submission of the case report, which was funded by Schering-Plough/MSD Portugal. The other authors declare no potential conflicts of interest relevant to this case report.


  1. 1.
    Schwartz D, Loftus E, Tremaine W, et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002; 122: 875–80PubMedCrossRefGoogle Scholar
  2. 2.
    Keighley M, Alan R. Current status and influence of operation on perianal Crohn's disease. Int J Colorectal Dis 1986; 1: 104–7PubMedCrossRefGoogle Scholar
  3. 3.
    Hellers G, Bergstrand O, Ewerths S et al. Occurrence and outcome after primary treatment of anal fistulas in Crohn's disease. Gut 1980; 21: 525–7PubMedCrossRefGoogle Scholar
  4. 4.
    Broe P, Bayless T, Cameron J. Crohn's disease: are enteroenteral fistulas an indication for surgery? Surgery 1982 Mar; 91(3): 249–53PubMedGoogle Scholar
  5. 5.
    Caprilli R, Gassull M, Escher J, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006; 55: 36–58CrossRefGoogle Scholar
  6. 6.
    Chambrun G, Peyrin-Biroulet L, Lémann M, et al. Clinical implications of mucosal healing for the management of IBD. Nat Rev Gastroenterol Hepatol 2010; 7: 15–29CrossRefGoogle Scholar
  7. 7.
    Sands B, Anderson F, Bernstein C, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004; 350: 876–85PubMedCrossRefGoogle Scholar
  8. 8.
    Sands B, Blank M, Patel K, et al. Long term treatment of rectovaginal fistula in Crohn's disease: response to infliximab in ACCENT II Study. Clin Gastroenterol Hepatol 2004; 2: 912–20PubMedCrossRefGoogle Scholar
  9. 9.
    Parsi M, Lashner B, Achkar J, et al. Type of fistula determines response to infliximab in patients with fistulous Crohn's disease. Am J Gastroenterol 2004; 99: 445–9PubMedCrossRefGoogle Scholar
  10. 10.
    Kim S, Yang K, Kim E, et al. Efficacy of infliximab in the treatment of Korean patients with Crohn's disease. Korean J Gastroenterol 2009; 54: 108–16PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2010

Authors and Affiliations

  • Joana Nunes
    • 1
    Email author
  • Paula M. Santos
    • 1
  • Lourdes Tavares
    • 1
  1. 1.Inflammatory Bowel Disease Clinic, Department of Gastroenterology and HepatologyHospital de Santa MariaLisbonPortugal

Personalised recommendations